Latest News

• 
  All Medical News

  EHA 2019: COLUMBA study

  Written by Alex Burton | 2 Jul 2019

  Article written by Maria Dalby. Interview by Hannah Chatfield. Another study with significant practice implications is the COLUMBA study, presented by Professor Maria-Victoria Mateos (University Hospital of Salamanca, Spain). This… read more.

• 
  All Medical News

  EHA 2019: Late-breaking abstracts at EHA

  Written by Alex Burton | 2 Jul 2019

  Article written by Maria Dalby. Interview by Hannah Chatfield. Oral selective BCL-2 inhibitor venetoclax has demonstrated encouraging clinical efficacy against MM. As monotherapy, venetoclax has shown to be… read more.

• 
  All Medical News

  PACIFIC and beyond – the promise of immunotherapy

  Written by Christine Clark | 10 May 2019

  Correvio Pharma has resubmitted a New Drug Application (NDA) to the US FDA seeking approval for Brinavess (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of adult patients with recent onset atrial fibrillation (AF).

• 
  All Medical News

  Advances in RRMM

  Written by Alex Burton | 9 May 2019

  Professor Kwee Yong (London, UK) details the results from the Tourmaline-MM3 study

• 
  All Medical News

  Transplantation, Consolidation and Maintenance

  Written by Alex Burton | 8 May 2019

    Autologous stem cell transplantation (ASCT) remains the standard of care option for those patients with newly-diagnosed multiple myeloma (MM) who are eligible for and able to tolerate… read more.

• 
  All Medical News

  Integrating CAR T-Cell therapy into the treatment of myeloma

  Written by Alex Burton | 7 May 2019

  Professor Julie Vose (Nebraska, USA) updates us on the current status of BCMA CAR T-cell therapy.

• 
  All Medical News

  State of the art clinical trials

  Written by Alex Burton | 6 May 2019

  Professor Sagar Lonial (Atlanta, USA) opened the UKMF by discussing the latest evidence in the management of myeloma, with comment from session chair Professor Gordon Cook (Leeds, UK).

• 
  All Medical News

  Bridging the gap between clinical trial results and real-world myeloma practices

  Written by Alex Burton | 5 May 2019

  Professor Graham Jackson (Newcastle, UK) gives an overview of his presentation  on real world management of myeloma patients in the UK, with comments from Professor Sagar Lonial (Atlanta, USA). Professor Jackson… read more.

• 
  All Medical News

  Maintenance therapy in newly diagnosed MM – a reality in the UK?

  Written by Alex Burton | 4 May 2019

  Professor Gordon Cook (Leeds, UK), Professor Guy Pratt (Birmingham, UK) and Professor Graham Jackson (Newcastle, UK) discuss the need for maintenance in the up-front setting for UK patients and the new data on… read more.

• 
  All Medical News

  What are the opportunities for genomic-driven change in lymphoma?

  Written by Alex Burton | 3 May 2019

  Dr Chris Fox (Nottingham, UK) highlights another presentation from Lymphoma SIG around the opportunities for genomic-driven change in lymphoma.

• 
  All Medical News

  Frontline therapy in multiple myeloma therapy: current evidence and future research

  Written by Alex Burton | 2 May 2019

  Professor Graham Jackson (Newcastle, UK) held a ‘meet the expert’ session at BSH 2019 covering the rapidly changing world of frontline therapy in myeloma.

• 
  All Medical News

  Highlights from BSH 2019

  Written by Alex Burton | 1 May 2019

  The 2019 annual meeting of the BSH showcased the best UK research with over 36 sessions covering a range of important issues related to the treatment of haematological… read more.